BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1532164)

  • 1. Effects of renin-angiotensin system blockade in guinea pigs.
    Véniant M; Clozel JP; Hess P; Fischli W
    Hypertension; 1992 Mar; 19(3):255-62. PubMed ID: 1532164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig.
    Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of renin inhibition and angiotensin converting enzyme inhibition upon bradykinin potentiation.
    Véniant M; Clozel JP; Fischli W
    J Hypertens; 1992 Feb; 10(2):155-60. PubMed ID: 1313478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs.
    el Amrani AI; Menard J; Gonzales MF; Michel JB
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):231-9. PubMed ID: 7692163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs.
    Clozel JP; Hess P; Schietinger K; Breu V; Fischli W; Baumgartner HR
    Life Sci; 1994; 54(6):PL87-92. PubMed ID: 8295484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro 42-5892 is a potent orally active renin inhibitor in primates.
    Fischli W; Clozel JP; el Amrani K; Wostl W; Neidhart W; Stadler H; Branca Q
    Hypertension; 1991 Jul; 18(1):22-31. PubMed ID: 1830563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the blockade of the renin-angiotensin system in cyclosporin-induced hypertension.
    Clozel JP; Fischli W; Ménard J
    J Hypertens; 1993 Jan; 11(1):75-81. PubMed ID: 8382242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
    Mervaala E; Dehmel B; Gross V; Lippoldt A; Bohlender J; Milia AF; Ganten D; Luft FC
    J Am Soc Nephrol; 1999 Aug; 10(8):1669-80. PubMed ID: 10446934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of three different potent renin inhibitors in primates.
    Clozel JP; Fischli W
    Hypertension; 1993 Jul; 22(1):9-17. PubMed ID: 8319997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the renin-angiotensin system in neointima formation after injury in rabbits.
    Janiak P; Libert O; Vilaine JP
    Hypertension; 1994 Dec; 24(6):671-8. PubMed ID: 7995623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat.
    K-Laflamme A; Oster L; Cardinal R; de Champlain J
    Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
    Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
    J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
    Holck M; Fischli W; Hefti F; Gerold M
    J Cardiovasc Pharmacol; 1986; 8(1):99-108. PubMed ID: 2419701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
    Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J
    Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin II in injury-induced neointima formation in rats.
    Osterrieder W; Müller RK; Powell JS; Clozel JP; Hefti F; Baumgartner HR
    Hypertension; 1991 Oct; 18(4 Suppl):II60-4. PubMed ID: 1833325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.